Dr Tushar SalukheMD MRCP
Consultant cardiologist and electrophysiologist
Dr Tushar Salukhe is a consultant cardiologist and electrophysiologist who treats private patients at Royal Brompton Hospital and 77 Wimpole Street.
He studied at Imperial College London, obtaining a first class degree in medical science in 1995, and then in 1998 qualified in medicine with distinctions. After training in internal medicine and getting his membership to the Royal College of Physicians (MRCP), Dr Salukhe won funding from the British Heart Foundation (BHF) to pursue his doctorate in pacing therapies for heart failure at the National Heart and Lung Institute.
In 2008, he gained his MD, and he continued researching as a fundamental aspect to his training. His specialist training included cardiology and electrophysiology at prominent centres, such as Royal Brompton, Hammersmith and St Mary’s hospitals in London.
In his penultimate year of training, Dr Salukhe spent time at the renowned University Medical Centre Hamburg-Eppendorf, Germany, on an advanced research programme.
Dr Tushar Salukhe provides care and treatment to patients who suffer with problems of heart rhythm or palpitations.
His areas of expertise include:
- care and treatment of patients with cardiac arrhythmias
- advanced mapping and ablation
- implantation of complex cardiac devices
- implantation of defibrillators and biventricular pacemakers
- ablation of atrial arrhythmia, in particular atrial fibrillation
- care and treatment of patients with vasovagal syncope (fainting or transient loss of consciousness)
- cardiac electrophysiology.
As well as clinical electrophysiology, Dr Salukhe leads the syncope service and non-invasive ECG monitoring at the Trust.
A full list of his publications is available on PubMed.
Dr Tushar Salukhe is an honorary senior lecturer at the National Heart and Lung Institute, Imperial College London. He also organises several training day programmes at the Royal Society of Medicine. His academic interests are:
- ablation endpoints for ablation of atrial fibrillation
- novel treatment for vasovagal syncope.